Get the Stockscreener App
1.09
1.87%
0.02
After Hours:
1.09
Pds Biotechnology Corporation Stock (PDSB) Forecast
The Pds Biotechnology Corporation (PDSB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.586, representing a +45.50% increase from the current price of $1.09. The highest analyst price target is $2.5462, and the lowest is $0.6257.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PDSB Price Target
Average 5.6213
(+415.71% Upside)
Is Pds Biotechnology Corporation (PDSB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 36.07 | Neutral |
| STOCH(9,6) | 35.50 | Neutral |
| STOCHRSI(14) | 20.12 | Neutral |
| MACD(12,26) | -0.0784 | Sell |
| ADX(14) | 31.70 | Sell |
| William %R | -73.03 | Neutral |
| CCI(14) | -93.34 | Neutral |
Buy: 0
Sell: 2
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.152
Sell
|
1.1438
Sell
|
| MA20 |
1.1915
Sell
|
1.2036
Sell
|
| MA50 |
1.399
Sell
|
1.3018
Sell
|
| MA100 |
1.3117
Sell
|
1.4024
Sell
|
| MA200 |
1.6683
Sell
|
1.7603
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, PDSB could be considered a Strong Sell, with 17 technical analysis indicators signaling 0 Buy signals, 12 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on PDSB, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 36.07 indicates that PDSB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 35.5 indicates that PDSB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 20.12 indicates that PDSB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 31.7 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -93.34 indicates that PDSB is still oversold but not to an extreme extent.
Long-term PDSB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Pds Biotechnology Corporation financial reports and earnings history, Pds Biotechnology Corporation (PDSB) stock could reach $4.018 by 2030, $1.8131 by 2040 and $4.5803 by 2050. See the projected annual prices until 2050 of the Pds Biotechnology Corporation stock below:
- Pds Biotechnology Corporation (PDSB) is expected to reach an average price of $2.9849 in 2035, with a high prediction of $3.517 and a low estimate of $0.6511. This indicates an $173.85% rise from the last recorded price of $1.09.
- Pds Biotechnology Corporation (PDSB) stock is projected to chart a bullish course in 2040, with an average price target of $0.6869, representing an $-36.98% surge from its current level. The forecast ranges from a conservative $0.0311 to a sky-high $1.8131.
- Our analysts predict Pds Biotechnology Corporation (PDSB) to jump 302.34% by 2045, soaring from $4.1632 to an average price of $4.3855, potentially reaching $4.4214. While $4.1632 is the low estimate, the potential upside is significant.
- Pds Biotechnology Corporation (PDSB) stock is expected to climb by 2050, reaching an average of $3.6504, a $234.90% jump from its current level. However, a wide range of estimates exists, with high and low targets of $4.5803 and $4.45, respectively, highlighting the market's uncertainty.
Pds Biotechnology Corporation Stock (PDSB) Year by Year Forecast
Pds Biotechnology Corporation Stock (PDSB) Price Forecast for 2025
Pds Biotechnology Corporation Stock (PDSB) is expected to reach an average price of $1.285 in 2025, with a high prediction of $2.5462 and a low estimate of $0.0239. This indicates an +17.89% rise from the last recorded price of $1.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| September, 2025 | $1.4812 | $0.6257 | $2.5462 | +35.89% |
| October, 2025 | $0.1139 | $0.1318 | $1.6302 | -89.55% |
| November, 2025 | $0.068 | $0.128 | $0.4441 | -93.76% |
| December, 2025 | $0.3881 | $0.1761 | $0.1281 | -64.39% |
Pds Biotechnology Corporation Stock (PDSB) Price Forecast for 2026
The predicted value for Pds Biotechnology Corporation (PDSB) in 2026 is set at an average of $7.8421. Estimates vary from a peak of $15.67 to a trough of $0.00959, indicating an +619.46% surge from the present price of $1.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.2422 | $0.4062 | $0.1862 | -77.78% |
| February, 2026 | $0.2763 | $0.2643 | $0.3757 | -74.65% |
| March, 2026 | $0.2996 | $0.00959 | $0.5196 | -72.51% |
| April, 2026 | $2.7395 | $0.1975 | $4.9822 | +151.33% |
| May, 2026 | $3.0754 | $0.9474 | $4.7714 | +182.14% |
| June, 2026 | $3.1613 | $1.7093 | $3.8813 | +190.03% |
| July, 2026 | $2.5012 | $1.8413 | $4.1272 | +129.46% |
| August, 2026 | $9.8171 | $2.3451 | $11.23 | +800.65% |
| September, 2026 | $8.5369 | $6.691 | $10.98 | +683.20% |
| October, 2026 | $9.0428 | $6.4689 | $9.7128 | +729.62% |
| November, 2026 | $13.36 | $7.1508 | $13.77 | +1,126% |
| December, 2026 | $12.70 | $11.83 | $15.67 | +1,065% |
Pds Biotechnology Corporation Stock (PDSB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Pds Biotechnology Corporation (PDSB) is $6.7811, with a high forecast of $12.65 and a low forecast of $0.9096. This indicates an +522.12% increase from the last price of $1.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $9.5145 | $8.8646 | $12.65 | +772.89% |
| February, 2027 | $7.9004 | $7.7304 | $10.69 | +624.81% |
| March, 2027 | $6.8403 | $5.6363 | $8.4168 | +527.55% |
| April, 2027 | $4.7162 | $4.2862 | $7.0943 | +332.68% |
| May, 2027 | $3.8821 | $2.5041 | $4.7902 | +256.16% |
| June, 2027 | $3.312 | $2.884 | $5.25 | +203.85% |
| July, 2027 | $4.1379 | $2.8059 | $5.0439 | +279.62% |
| August, 2027 | $3.1238 | $2.9838 | $4.7258 | +186.59% |
| September, 2027 | $3.3637 | $1.4457 | $4.1017 | +208.59% |
| October, 2027 | $1.3496 | $0.9096 | $3.2876 | +23.81% |
| November, 2027 | $2.3355 | $1.4135 | $2.4755 | +114.26% |
| December, 2027 | $3.4453 | $1.6434 | $3.8603 | +216.09% |
Pds Biotechnology Corporation Stock (PDSB) Price Forecast for 2028
In 2028, Pds Biotechnology Corporation (PDSB) is projected to reach an average price of $6.3689, with a high projection of $11.78 and a low estimate of $0.9611. This indicates an +484.31% rise from the last price of $1.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.2412 | $1.9673 | $3.8393 | +105.62% |
| February, 2028 | $1.0371 | $1.0371 | $2.4392 | -4.85% |
| March, 2028 | $3.327 | $0.9611 | $3.673 | +205.23% |
| April, 2028 | $6.5729 | $2.881 | $7.6789 | +503.02% |
| May, 2028 | $7.8928 | $6.0569 | $8.4628 | +624.11% |
| June, 2028 | $7.3387 | $6.9987 | $11.78 | +573.28% |
| July, 2028 | $6.5446 | $6.1206 | $7.9827 | +500.42% |
| August, 2028 | $4.6245 | $4.4696 | $7.1486 | +324.26% |
| September, 2028 | $4.0004 | $3.5764 | $5.2185 | +267.01% |
| October, 2028 | $4.7363 | $3.8894 | $5.4244 | +334.52% |
| November, 2028 | $7.6462 | $4.5453 | $8.4962 | +601.48% |
| December, 2028 | $3.2721 | $2.7901 | $7.7746 | +200.19% |
Pds Biotechnology Corporation Stock (PDSB) Price Forecast for 2029
The 2029 price forecast for Pds Biotechnology Corporation Stock (PDSB) is $2.8467 on average, with a high prediction of $5.1835 and a low estimate of $0.51. This represents an +161.17% increase from the previous price of $1.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.9769 | $2.926 | $4.254 | +264.86% |
| February, 2029 | $4.2478 | $2.8899 | $4.6439 | +289.71% |
| March, 2029 | $3.6337 | $3.5937 | $4.7917 | +233.37% |
| April, 2029 | $2.8196 | $2.1857 | $3.9177 | +158.68% |
| May, 2029 | $3.6695 | $2.1176 | $3.8395 | +236.65% |
| June, 2029 | $3.5954 | $3.3494 | $5.1835 | +229.86% |
| July, 2029 | $3.3313 | $3.0934 | $3.8873 | +205.63% |
| August, 2029 | $3.7312 | $2.3032 | $4.3312 | +242.31% |
| September, 2029 | $3.8171 | $3.3331 | $4.0802 | +250.19% |
| October, 2029 | $3.037 | $2.893 | $5.089 | +178.62% |
| November, 2029 | $1.0779 | $1.0229 | $3.336 | -1.11% |
| December, 2029 | $0.89 | $0.51 | $2.2648 | -18.35% |
Pds Biotechnology Corporation Stock (PDSB) Price Forecast for 2030
Pds Biotechnology Corporation Stock (PDSB) is expected to reach an average price of $2.1653 in 2030, with a high forecast of $4.3055 and a low forecast of $0.0252. This signifies an +98.65% surge from the last price of $1.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.7098 | $0.318 | $4.018 | -34.88% |
| February, 2030 | $0.6516 | $0.2257 | $1.4137 | -40.22% |
| March, 2030 | $1.2334 | $0.2955 | $1.3654 | +13.15% |
| April, 2030 | $0.3052 | $0.0252 | $1.2513 | -72.00% |
| May, 2030 | $1.8885 | $0.0331 | $1.7751 | +73.26% |
| June, 2030 | $1.9333 | $1.7492 | $1.5822 | +77.36% |
| July, 2030 | $3.0235 | $2.3053 | $2.7235 | +177.39% |
| August, 2030 | $2.7817 | $2.6897 | $2.7956 | +155.20% |
| September, 2030 | $2.3699 | $2.5888 | $2.4179 | +117.42% |
| October, 2030 | $3.7502 | $2.722 | $3.0502 | +244.05% |
| November, 2030 | $4.2136 | $3.7722 | $3.8684 | +286.56% |
| December, 2030 | $4.3506 | $4.3712 | $4.3055 | +299.13% |
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):